Skip to main content

Peer Review reports

From: ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer

Original Submission
4 Jun 2021 Submitted Original manuscript
8 Jul 2021 Author responded Author comments - S. Lindsey Davis
Resubmission - Version 2
8 Jul 2021 Submitted Manuscript version 2
9 Aug 2021 Reviewed Reviewer Report
20 Oct 2021 Reviewed Reviewer Report
11 Jan 2022 Author responded Author comments - S. Lindsey Davis
Resubmission - Version 3
11 Jan 2022 Submitted Manuscript version 3
16 Feb 2022 Reviewed Reviewer Report
17 Feb 2022 Reviewed Reviewer Report
6 May 2022 Author responded Author comments - S. Lindsey Davis
Resubmission - Version 4
6 May 2022 Submitted Manuscript version 4
18 May 2022 Reviewed Reviewer Report
1 Jul 2022 Author responded Author comments - S. Lindsey Davis
Resubmission - Version 5
1 Jul 2022 Submitted Manuscript version 5
26 Jul 2022 Reviewed Reviewer Report
16 Aug 2022 Author responded Author comments - S. Lindsey Davis
Resubmission - Version 6
16 Aug 2022 Submitted Manuscript version 6
Publishing
11 Sep 2022 Editorially accepted
29 Oct 2022 Article published 10.1186/s12885-022-10084-7

You can find further information about peer review here.

Back to article page